ALK or ROS1-positive NSCLC
Also known as: Non Small Cell Lung Cancer ALK Positive or ROS1 Positive / ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB08865 | Crizotinib | 1 / 2 | Completed | 1 |
| DB12130 | Lorlatinib | 1 / 2 | Completed | 1 |
| DB08865 | Crizotinib | 4 | Terminated | 1 |
| DB12130 | Lorlatinib | Not Available | No Longer Available | 1 |